Oral administration formulation of blueberry extract as coadjuvant for preserving health of human precorneal film

The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the...

Full description

Saved in:
Bibliographic Details
Main Authors SANTOS GARCIA ARTURO, CHAVEZ GARCIA JOSE ALONSO, GONZALEZ DE LA ROSA ALEJANDRO, ALTAMIRANO VALLEJO JUAN CARLOS
Format Patent
LanguageChinese
English
Published 25.09.2020
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a nutraceutical formulation of blueberry extract, fish oil (omega-3 and omega-6), recombinant human lactoferrin, vitamin A and vitamin E, for human oral consumption. The invention belongs to the field of ophthalmology and has been developed as a coadjuvant for preserving the health of the precorneal film and of the eye surface. The formulation contains an extract of natural origin (Vaccinium myrtillus L) with antioxidant and anti-inflammatory properties; it also uses eicosapentaenoic acid (EPA), omega-6, and docosahexaenoic acid (DHA), omega-3, obtained from fish oil and which, together with lactoferrin, vitamin A and vitamin E, improves tear quality, since these compounds have anti-microbial and anti-inflammatory effects. The formulation has been designed as a coadjuvant for preserving the health of the precorneal film. No formulation for oral administration of a blueberry extract together with lactoferrin, in combination with vitamin A, vitamin E and fish oil(eicosapentaenoic acid a
Bibliography:Application Number: CN201880088073